EN

BMCC生醫商品化中心

發掘優良案源串連國際
發掘優良案源串連國際
專業商化輔導團隊
發掘優良案源串連國際

我要諮詢

2023.02.22    生醫新 show~路明思生技
2023.02.22    生醫新 show~賽爾奈維生醫
2023.02.22    生醫新 show~倍利科技
2023.02.22    實驗記錄本撰寫
2023.02.22    專案管理
2023.02.22    法規原則與考量
2023.02.22    評估利器TPP 目標產品概況
2023.02.22    跨領域整合特色
2023.02.22    臨床試驗簡介
2023.02.22    跨越死亡之谷的第一步
2023.02.10    觀念驗證POC
2023.02.09    趨勢報告：疫情浪潮退去，醫藥開發成本上升、獲利反降
2023.02.09    搶頭香！向榮生技治療膝骨關節炎臨床三期獲准執行
2023.02.09    百健(Biogen)與Sage Therapeutics聯手開發憂鬱症新藥
2023.02.06    慢性腎病導致貧血治療突破，GSK 口服 Jesduvoq獲美國FDA核准
2023.02.06    逆齡回春不是夢?哈佛研究證明小鼠衰老是可逆的
2023.02.06    巨生醫MPB-1523 將登國際期刊
2023.02.05    看不見病毒的防疫進行式──長新冠、兒童腦炎、MIS-C的診治與解謎
2022.11.28    DCB2023精準健康產業徵題活動辦法
2022.11.02    ATC 抗體藥物研討會
2022.11.02    非酒精性脂肪肝炎藥物研發現況
2022.11.02    非酒精性脂肪肝炎簡述與治療現況
2022.10.28    廣達：人體就是元宇宙 透過數位分身打造精準醫療
2023.02.06    AI臨床決策輔助之應用
2023.02.06    COVID-19檢測台灣與全球市場現況
2023.02.06    新時代mRNA疫苗的臨床產業化之路
2022.05.19    淺談囊狀纖維化用藥市場開發狀況
2022.04.19    精準診斷早期Tau病變的發展現況
2022.03.08    新興mRNA疫苗的生產製程概述
2022.06.27    「國際商務起手式：1-on-1 partnering 教戰手冊」視訊研討會

潛力案源

生醫商品化中心藥品領域針對藥物發展及商品化的過程中可能遭遇到的各項問題或瓶頸，以輔導育成團隊角色，提供整合性的資源

更多案源
A Monoclonal Antibody against Misfolded TDP-43 for Neurodegenerative Diseases without Perturbing Native TDP-43 TDP-O antibody is a selective conformational antibody specific for misfolded TDP-43 oligomers to combat ALS and TDP-43 proteinop...
3D Digital Pathology with MetaLite Software and AI-enabled Analysis for Precision Diagnosis JelloX Biotech Inc. retrieves 3D digital pathology big data from clinical specimen including solid tumor tissues and regenerativ...
Integrated Continuous Bioprocessing Platform Integrated Continuous Bioprocessing Platform
Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells Quantity and Quality Controlled Bioprocess of Chimeric Antigen Receptor (CAR)-T Cells
Treatment of Cancers with Refolding Human Serum Albumin Treatment of cancers with refolding human serum albumin
The Second Generation of αIIbβ3 Antagonist Prevent Thrombosis without the Risk of Bleeding The Second Generation of αIIbβ3 Antagonist Prevent Thrombosis without the Risk of Bleeding
Synthetic Peptide of Tumor Associated Antigen L6-based Cancer Immunotherapy Synthetic Peptide of Tumor Associated Antigen L6-based Cancer Immunotherapy
Hyperactive Factor IX Variant “FIX-TripleL” for Hemophilia B Superior activity! Safety! Efficacy!
High Yield CHO-C Expression System High Yield CHO-C Expression System
Neural Rejuvenation, a Novel Therapeutic Strategy for Neurodegenerative Diseases J4 is a novel compound that provides a first-in-class approach to address the fundamental issue of insufficient energy supply in...
A Novel HDAC6 Inhibitor, MPT0G211, for Cancer Treatment MPT0G211 is a highly selective small molecular against HDAC6 with the best pharmacological profile.
KRAS Reducer Suppresses Pancreatic Cancer Malignancy SW1 is an ADAM9 inhibitor that can promote KRAS protein degradation and enhances the efficacy of gemcitabine in pancreatic cance...
Novel γ-globinHbF Inducer for Treatment of Sickle Cell Disease (SCD) and β–thalassemia AS-28 is a potent and orally active compound which can induce γ-globin expression in hydroxyurea (HU) non-responsive erythroid c...
Vaccine Antigens against Acinetobacter baumannii Novel Antigens for Preventing the Nosocomial Bacterial Infection
Recombinant Lipoprotein Technology in Cancer Immunotherapy Recombinant Lipoprotein Technology in Cancer Immunotherapy
Targeted Antigen Delivery System Targeted Antigen Delivery System
Minimal Residual Disease (MRD) Detection of NSCLC with Microfluidic-Capture Microdissection (MCM) System The SACA system, which utilizes a variety of technology including a dynamic Live- cell Staining Microdialysis Chip and Patient-D...
Tumor-Infiltrating Lymphocytes (TILs) Isolation with Microfluidic-Capture Microdissection (MCM) System The SACA system, which utilizes a variety of technology including a dynamic Live- cell Staining Microdialysis Chip and Patient-D...

專業服務

推動包含 4 大行動主軸，由強化人才、資金、智財、法規、資源、選題等六大構面著手，整合資源及育成輔導、加強產學研機技術支援平臺等。

BMCC生醫商品化中心

技術研發

技術研發

鞏固核心技術
定位研發方向
建立技術價值

了解更多
BMCC生醫商品化中心

產品醫化

產品醫化

確認目標市場
控制專案成本
建立產品競爭優勢

了解更多
BMCC生醫商品化中心

公司新創

公司新創

瞭解市場競爭趨勢
確立商業模式
尋求政府及民間資源挹注

了解更多
BMCC生醫商品化中心

公司茁壯

公司茁壯

連結國際合作夥伴
提升公司智財價值
強化公司競爭力

了解更多